AppTech Engages CORE IR for Investor Relations and Shareholder Communications Services
CARLSBAD, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — AppTech Payments Corp. (Nasdaq:APCX) (“AppTech” or the “Company”), a pioneering Fintech company powering […]
Tilray Launches Cannabis-Infused Premium Belgian Chocolates With Chowie Wowie Edibles Brand
Chowie Wowie Introduces New Soft Caramel and Crunchy Praline Flavours Newly Formulated Classics include Top-Selling THC Milk Chocolate, and Balanced […]
ARKO Corp. Appoints Robert Giammatteo as Chief Financial Officer
RICHMOND, Va., Dec. 21, 2023 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company […]
Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension
CNM-Au8 30mg treatment demonstrated significantly reduced plasma neurofilament light chain (NfL) levels at 76 weeks relative to placebo (18 months […]
Clene Provides Update on ALS Clinical Development Meeting With FDA
SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its […]
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
– MeiraGTx enters into an Asset Purchase Agreement related to botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked […]
Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction
Agreement signed following positive pre-clinical data demonstrating a one-time treatment with PLX-PAD significantly increased neurogenesis, offering immediate, long-term therapeutic effect […]
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
Expands clinical development of GC012F in rSLE following FDA IND clearance for Phase 1/2 trial in the United States Gracell […]
Medigus: ParaZero Successfully Completed its Drone Safety Project with a Fortune 500 Leading Automotive Manufacturer
ParaZero is furthering its collaboration with the same esteemed customer, having recently secured an additional order Tel Aviv, Israel, Dec. […]
Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design
MALVERN, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused […]
